Compare $BCAB vs $BIXT | Chartloom

Compare

$BCAB vs $BIXT

Bioatla Inc · Bioxytran Inc

BCAB

Bioatla Inc

BIXT

Bioxytran Inc

Compare $BCAB vs $BIXT

Comparing Bioatla Inc and Bioxytran Inc

BCABBioatla Inc

BIXTBioxytran Inc

BCABBioatla Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-22.7%

YTD performance

-94.4%

52W performance

-96.7%

FCF yield

-943.1%

BIXTBioxytran Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-68.2%

52W performance

-67.7%

FCF yield

-34.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BCAB

BIXT

Detailed metrics comparison

BCAB

Bioatla Inc

BIXT

Bioxytran Inc

Market Cap

BCAB$2M

BIXT$3M

Enterprise Value

BCAB$946K

BIXT$4M

Price

BCAB$1.50

BIXT$0.02

P/E Ratio

BCABN/A

BIXTN/A

P/S Ratio

BCAB0.29x

BIXT18.76x

EV/Sales

BCAB0.11x

BIXT19.26x

EV/EBITDA

BCAB0.00x

BIXT121.99x

P/B Ratio

BCAB4.57x

BIXT4.86x

P/FCF Ratio

BCABN/A

BIXTN/A

EV/FCF

BCAB-0.04x

BIXT-4.08x

PEG Ratio

BCABN/A

BIXTN/A

Forward P/E (NTM)

BCABN/A

BIXTN/A

Forward P/S (NTM)

BCABN/A

BIXTN/A

Revenue (TTM)

BCAB$9M

BIXT$0

Revenue Growth (YoY)

BCAB-22.7%

BIXTN/A

Forward Rev Growth

BCAB0.0%

BIXT0.0%

Gross Margin (TTM)

BCAB0.0%

BIXT47.4%

Operating Margin (TTM)

BCAB0.0%

BIXT0.0%

EBITDA Margin (TTM)

BCAB-369.8%

BIXT0.0%

Net Margin (TTM)

BCAB-370.0%

BIXT0.0%

FCF Margin (TTM)

BCAB-276.3%

BIXTN/A

Net Income (TTM)

BCAB$-31M

BIXT$-3M

FCF (TTM)

BCAB$-23M

BIXT$-893K

EPS (TTM)

BCAB-$18.93

BIXT-$0.03

ROE (TTM)

BCAB-35792.0%

BIXT-755.0%

ROA (TTM)

BCAB-26317.0%

BIXT-79248.0%

ROIC (TTM)

BCAB-35792.0%

BIXT-612.0%

Cash

BCAB$2M

BIXT$177K

Debt

BCAB$0

BIXT$1M

Net Cash/Debt

BCAB$2M

BIXT$-1M

Current Ratio (TTM)

BCAB0.20x

BIXT0.03x

Quick Ratio (TTM)

BCAB0.17x

BIXT0.03x

Debt/Equity (TTM)

BCAB0.00x

BIXT0.20x

Debt/Assets (TTM)

BCAB0.0%

BIXT0.0%

Interest Coverage (TTM)

BCABN/A

BIXTN/A

Net Debt/EBITDA (TTM)

BCAB0.00x

BIXT0.00x

Beta

BCAB0.63

BIXT2.80

52W Performance

BCAB-96.7%

BIXT-67.7%

YTD Performance

BCAB-94.4%

BIXT-68.2%

% from 52W High

BCAB-97.9%

BIXT-75.9%

% from 52W Low

BCAB40.2%

BIXT14.5%

Asset Turnover (TTM)

BCAB0.73x

BIXT0.50x

FCF Yield (TTM)

BCAB-943.1%

BIXT-34.2%

Earnings Yield (TTM)

BCAB-1263.2%

BIXT-133.6%

Dividend Yield (TTM)

BCABN/A

BIXTN/A

Rule of 40

BCAB-299.0

BIXT0.0

EV/GP/RG

BCABN/A

BIXTN/A

Ticker research

View BCAB research View BIXT research

Metric	BCAB Bioatla Inc	BIXT Bioxytran Inc
Market & Valuation
Market Cap	$2M	$3M
Enterprise Value	$946K	$4M
Price	$1.50	$0.02
P/E Ratio	N/A	N/A
P/S Ratio	0.29x	18.76x
EV/Sales	0.11x	19.26x
EV/EBITDA	0.00x	121.99x
P/B Ratio	4.57x	4.86x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.04x	-4.08x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$9M	$0
Revenue Growth (YoY)	-22.7%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	47.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-369.8%	0.0%
Net Margin (TTM)	-370.0%	0.0%
FCF Margin (TTM)	-276.3%	N/A
Net Income (TTM)	$-31M	$-3M
FCF (TTM)	$-23M	$-893K
EPS (TTM)	-$18.93	-$0.03
ROE (TTM)	-35792.0%	-755.0%
ROA (TTM)	-26317.0%	-79248.0%
ROIC (TTM)	-35792.0%	-612.0%
Financial Health
Cash	$2M	$177K
Debt	$0	$1M
Net Cash/Debt	$2M	$-1M
Current Ratio (TTM)	0.20x	0.03x
Quick Ratio (TTM)	0.17x	0.03x
Debt/Equity (TTM)	0.00x	0.20x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.63	2.80
52W Performance	-96.7%	-67.7%
YTD Performance	-94.4%	-68.2%
% from 52W High	-97.9%	-75.9%
% from 52W Low	40.2%	14.5%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.50x
FCF Yield (TTM)	-943.1%	-34.2%
Earnings Yield (TTM)	-1263.2%	-133.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-299.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BCAB research	View BIXT research

Valuation

P/S Ratio

BCAB

0.29x

BIXT

18.76x

EV/FCF

BIXT

-4.08x

BCAB

-0.04x

Growth & revenue

Revenue Growth TTM

BCAB

-22.7%

Forward Revenue Growth

BCAB

0.0%

BIXT

0.0%

Profitability & performance

Gross Margin

BIXT

47.4%

BCAB

0.0%

ROE

BIXT

-755.0%

BCAB

-35792.0%

FCF Yield %

BIXT

-34.2%

BCAB

-943.1%

52-Week Performance

BIXT

-67.7%

BCAB

-96.7%

Detailed metrics comparison

BCAB

Bioatla Inc

BIXT

Bioxytran Inc

Market Cap

BCAB$2M

BIXT$3M

Enterprise Value

BCAB$946K

BIXT$4M

Price

BCAB$1.50

BIXT$0.02

P/E Ratio

BCABN/A

BIXTN/A

P/S Ratio

BCAB0.29x

BIXT18.76x

EV/Sales

BCAB0.11x

BIXT19.26x

EV/EBITDA

BCAB0.00x

BIXT121.99x

P/B Ratio

BCAB4.57x

BIXT4.86x

P/FCF Ratio

BCABN/A

BIXTN/A

EV/FCF

BCAB-0.04x

BIXT-4.08x

PEG Ratio

BCABN/A

BIXTN/A

Forward P/E (NTM)

BCABN/A

BIXTN/A

Forward P/S (NTM)

BCABN/A

BIXTN/A

Revenue (TTM)

BCAB$9M

BIXT$0

Revenue Growth (YoY)

BCAB-22.7%

BIXTN/A

Forward Rev Growth

BCAB0.0%

BIXT0.0%

Gross Margin (TTM)

BCAB0.0%

BIXT47.4%

Operating Margin (TTM)

BCAB0.0%

BIXT0.0%

EBITDA Margin (TTM)

BCAB-369.8%

BIXT0.0%

Net Margin (TTM)

BCAB-370.0%

BIXT0.0%

FCF Margin (TTM)

BCAB-276.3%

BIXTN/A

Net Income (TTM)

BCAB$-31M

BIXT$-3M

FCF (TTM)

BCAB$-23M

BIXT$-893K

EPS (TTM)

BCAB-$18.93

BIXT-$0.03

ROE (TTM)

BCAB-35792.0%

BIXT-755.0%

ROA (TTM)

BCAB-26317.0%

BIXT-79248.0%

ROIC (TTM)

BCAB-35792.0%

BIXT-612.0%

Cash

BCAB$2M

BIXT$177K

Debt

BCAB$0

BIXT$1M

Net Cash/Debt

BCAB$2M

BIXT$-1M

Current Ratio (TTM)

BCAB0.20x

BIXT0.03x

Quick Ratio (TTM)

BCAB0.17x

BIXT0.03x

Debt/Equity (TTM)

BCAB0.00x

BIXT0.20x

Debt/Assets (TTM)

BCAB0.0%

BIXT0.0%

Interest Coverage (TTM)

BCABN/A

BIXTN/A

Net Debt/EBITDA (TTM)

BCAB0.00x

BIXT0.00x

Beta

BCAB0.63

BIXT2.80

52W Performance

BCAB-96.7%

BIXT-67.7%

YTD Performance

BCAB-94.4%

BIXT-68.2%

% from 52W High

BCAB-97.9%

BIXT-75.9%

% from 52W Low

BCAB40.2%

BIXT14.5%

Asset Turnover (TTM)

BCAB0.73x

BIXT0.50x

FCF Yield (TTM)

BCAB-943.1%

BIXT-34.2%

Earnings Yield (TTM)

BCAB-1263.2%

BIXT-133.6%

Dividend Yield (TTM)

BCABN/A

BIXTN/A

Rule of 40

BCAB-299.0

BIXT0.0

EV/GP/RG

BCABN/A

BIXTN/A

Ticker research

View BCAB research View BIXT research

Metric	BCAB Bioatla Inc	BIXT Bioxytran Inc
Market & Valuation
Market Cap	$2M	$3M
Enterprise Value	$946K	$4M
Price	$1.50	$0.02
P/E Ratio	N/A	N/A
P/S Ratio	0.29x	18.76x
EV/Sales	0.11x	19.26x
EV/EBITDA	0.00x	121.99x
P/B Ratio	4.57x	4.86x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.04x	-4.08x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$9M	$0
Revenue Growth (YoY)	-22.7%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	47.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-369.8%	0.0%
Net Margin (TTM)	-370.0%	0.0%
FCF Margin (TTM)	-276.3%	N/A
Net Income (TTM)	$-31M	$-3M
FCF (TTM)	$-23M	$-893K
EPS (TTM)	-$18.93	-$0.03
ROE (TTM)	-35792.0%	-755.0%
ROA (TTM)	-26317.0%	-79248.0%
ROIC (TTM)	-35792.0%	-612.0%
Financial Health
Cash	$2M	$177K
Debt	$0	$1M
Net Cash/Debt	$2M	$-1M
Current Ratio (TTM)	0.20x	0.03x
Quick Ratio (TTM)	0.17x	0.03x
Debt/Equity (TTM)	0.00x	0.20x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.63	2.80
52W Performance	-96.7%	-67.7%
YTD Performance	-94.4%	-68.2%
% from 52W High	-97.9%	-75.9%
% from 52W Low	40.2%	14.5%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.50x
FCF Yield (TTM)	-943.1%	-34.2%
Earnings Yield (TTM)	-1263.2%	-133.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-299.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BCAB research	View BIXT research